PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals: Products & infrastructure

PhaseBio Pharmaceuticals has 13 clinical trials on record, 0 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

PhaseBio Pharmaceuticals has 13 clinical trials on record, 0 under way.

13clinical trials
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 5 more records
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement t…
phase 2 · stopped or withdrawn · 54 participants · Acute Respiratory Distress Syndrome; Coronavirus; Hypoxic Respiratory Failure; …
Jul 2020
Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT…
phase 2 · stopped or withdrawn · 25 participants · Pulmonary Arterial Hypertension
Apr 2019
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Sym…
phase 2 · stopped or withdrawn · 35 participants · Pulmonary Arterial Hypertension
Jul 2018
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
phase 1 · completed · 3 participants · Pulmonary Arterial Hypertension
Oct 2017
Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF
phase 2 · completed · 29 participants · Heart Failure
Jun 2016
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
phase 2 · completed · 37 participants · Type 2 Diabetes Mellitus
Oct 2015
Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Phar…
phase 1 · completed · 20 participants · Essential Hypertension
Jun 2013
Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynami…
phase 1 · completed · 37 participants · Type 2 Diabetes Mellitus (T2DM)
Apr 2013
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.